Alzheimer Disease Clinical Trial
— REACHOfficial title:
Coordinating Center for Multisite Intervention Trial for Diverse Caregivers
| Verified date | January 2016 |
| Source | University of Pittsburgh |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Federal Government |
| Study type | Interventional |
The primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders. The overall objectives of study are to 1) identify and reduce modifiable risk factors among diverse family caregivers of patients with Alzheimer's Disease or a related disorder, 2) enhance the quality of care of the care recipients, and 3) enhance the well-being of the caregivers.
| Status | Completed |
| Enrollment | 613 |
| Est. completion date | September 2005 |
| Est. primary completion date | September 2005 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 21 Years and older |
| Eligibility |
Caregiver Inclusion/Exclusion Criteria: - Inclusion Criteria: 1. Age: 21 years or older 2. Family member of the care recipient 3. Must live with care recipient or share cooking facilities 4. Must have a telephone that will enable use of CTIS (Computer Telephone Integration System) system 5. Must plan to remain in the recruitment area for the duration of the intervention and follow-up 6. Caregiver role for more than 6 months 7. Must provide on average 4 hours of supervision or direct assistance per day for the care recipient 8. Risk Screening Tool: must have a total score of at least 1 for questions 1-3, and a total of at least 2 for questions 4-9 Exclusion Criteria: 1. Non-English, non-Spanish speaking 2. Active treatment (chemotherapy, radiation therapy) for cancer 3. Imminent placement of care recipient into a nursing home or with another caregiver (within 6 months) 4. Involvement in another clinical trial for caregivers 5. Participant in REACH I study 6. SPMSQ:> or = 4 errors* - If the caregiver has been inconsistent with answers or repeated answers during the screening process, then the interviewer administers the Short Portable Mental Status Questionnaire (SPMSQ). If the caregiver missed 4 or more questions, he/she was excluded from the study. Care Recipient Inclusion/Exclusion Criteria Inclusion Criteria: a. NINCDS (MD diagnosis) of dementia or cognitive impairment (raw score on MMSE of 23 or less) Exclusion Criteria: 1. Non-English, non-Spanish speaking 2. History of Parkinson's Disease or a stroke with no reported decline in memory over the past year 3. Active treatment (chemotherapy, radiation therapy) for cancer 4. More than three acute medical hospitalizations in past year (other than psychiatric or Alzheimer's Disease related admission) 5. Schizophrenia (onset of delusions before age 45) or other severe mental illness 6. Dementia secondary to head trauma (probable) 7. Blindness or deafness if either disability prohibits them from completion of data collection or participation in the interventions 8. MMSE = 0 and Bedbound (confined to a bed or chair for >22 hours per day, for at least 4 of the past 7 days) 9. Planned nursing home admission in 6 months 10. Participant in REACH I study |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Alabama at Birmingham | Birmingham | Alabama |
| United States | University of Tennessee Health Science Center | Memphis | Tennessee |
| United States | Stanford University and Veterans Affairs | Menlo Park | California |
| United States | University of Miami at Miami, Center on Adult Development and Aging | Miami | Florida |
| United States | Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health | Philadelphia | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| University of Pittsburgh | National Institute of Nursing Research (NINR), National Institute on Aging (NIA) |
United States,
Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, Gitlin LN, Klinger J, Koepke KM, Lee CC, Martindale-Adams J, Nichols L, Schulz R, Stahl S, Stevens A, Winter L, Zhang S; Resources for Enhancing Alzheimer's Caregiver Health (REACH) II I — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | multivariate quality of life indicator- assessed caregiver burden, depressive symptoms, self-care, social support and patient problem behaviors. Assessed at six months post-randomization. | six months | No | |
| Secondary | Caregiver clinical depression and patient institutional placement-six months post-randomization. | six months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
| Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
| Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
| Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
| Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
| Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
| Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
| Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |